🇺🇸 FDA
Patent

US 7799798

Spiroheterocyclic compounds and their uses as therapeutic agents

granted A61PA61P1/00A61P11/00

Quick answer

US patent 7799798 (Spiroheterocyclic compounds and their uses as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/00, A61P11/00, A61P11/06, A61P13/02